Literature DB >> 18539348

Future costs and the future of cost-effectiveness analysis.

Alan M Garber1, Charles E Phelps.   

Abstract

Mesh：

Year:  2008        PMID： 18539348      PMCID： PMC2574706          DOI： 10.1016/j.jhealeco.2008.05.002

Source DB:  PubMed          Journal:  J Health Econ        ISSN： 0167-6296            Impact factor:   3.883


× No keyword cloud information.
  3 in total

1.  Accounting for future costs in medical cost-effectiveness analysis.

Authors:  D Meltzer
Journal:  J Health Econ       Date:  1997-02       Impact factor: 3.883

2.  Economic foundations of cost-effectiveness analysis.

Authors:  A M Garber; C E Phelps
Journal:  J Health Econ       Date:  1997-02       Impact factor: 3.883

3.  Satisfaction guaranteed--"payment by results" for biologic agents.

Authors:  Alan M Garber; Mark B McClellan
Journal:  N Engl J Med       Date:  2007-10-18       Impact factor: 91.245
  3 in total
  9 in total

Review 1.  Unrelated medical costs in life-years gained: should they be included in economic evaluations of healthcare interventions?

Authors:  David R Rappange; Pieter H M van Baal; N Job A van Exel; Talitha L Feenstra; Frans F H Rutten; Werner B F Brouwer
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

2.  Korean guidelines for pharmacoeconomic evaluation (second and updated version) : consensus and compromise.

Authors:  Seungjin Bae; Soook Lee; Eun Young Bae; Sunmee Jang
Journal:  Pharmacoeconomics       Date:  2013-04       Impact factor: 4.981

Review 3.  Cost-utility studies in upper limb orthopaedic surgery: a systematic review of published literature.

Authors:  P V Rajan; Rameez A Qudsi; G S M Dyer; E Losina
Journal:  Bone Joint J       Date:  2018-11       Impact factor: 5.082

Review 4.  Modelling the cost-effectiveness of total knee arthroplasty: A systematic review.

Authors:  Achi Kamaraj; Kendrick To; Kt Matthew Seah; Wasim S Khan
Journal:  J Orthop       Date:  2020-10-08

5.  Cost-effectiveness of cardiac resynchronization therapy in the MADIT-CRT trial.

Authors:  Katia Noyes; Peter Veazie; William Jackson Hall; Hongwei Zhao; April Buttaccio; Kelly Thevenet-Morrison; Arthur J Moss
Journal:  J Cardiovasc Electrophysiol       Date:  2012-08-22

Review 6.  Evaluating Cost-effectiveness of Interventions That Affect Fertility and Childbearing: How Health Effects Are Measured Matters.

Authors:  Jeremy D Goldhaber-Fiebert; Margaret L Brandeau
Journal:  Med Decis Making       Date:  2015-04-29       Impact factor: 2.749

7.  Future costs in cost-effectiveness analysis: an empirical assessment.

Authors:  Marie Kruse; Jan Sørensen; Dorte Gyrd-Hansen
Journal:  Eur J Health Econ       Date:  2010-09-28

8.  Cost-effectiveness of pharmacotherapy to reduce obesity.

Authors:  J Lennert Veerman; Jan J Barendregt; Megan Forster; Theo Vos
Journal:  PLoS One       Date:  2011-10-27       Impact factor: 3.240

9.  Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty for Stable Coronary Artery Disease.

Authors:  James Lomas; Miqdad Asaria; Laura Bojke; Chris P Gale; Gerry Richardson; Simon Walker
Journal:  Pharmacoecon Open       Date:  2018-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.